alocelyvir
Cell therapyexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 19, 2021 (NCT04758533)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05047276 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2021 | Hospital Universitari de Bellvitge, Universidad Carlos III Madrid, University of Barcelona |
| NCT04758533 | Phase 1/Phase 2 (Phase 2) | Apr 19, 2021 | Apices Soluciones S.L., Hospital Infantil Universitario Niño Jesús, Hospital Infantil Universitario Niño Jesús, Madrid, Spain |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Apices Soluciones S.L. | For profit | 1 | 0 | 1 | 2021 |
| Hospital Infantil Universitario Niño Jesús | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Hospital Infantil Universitario Niño Jesús, Madrid, Spain | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Hospital Universitari de Bellvitge | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Universidad Carlos III Madrid | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Barcelona | Academic/Hospital | 1 | 0 | 1 | 2021 |
6 organizations
Page 1 / 1